<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-05-10" modified="2020-10-07" version="177">
<accession>Q7Z434</accession>
<accession>A8K6X0</accession>
<accession>B2BD33</accession>
<accession>B2BD34</accession>
<accession>F5H6C8</accession>
<accession>M1P2Z0</accession>
<accession>Q2HWT5</accession>
<accession>Q3I0Y2</accession>
<accession>Q5T7I6</accession>
<accession>Q86VY7</accession>
<accession>Q9H1H3</accession>
<accession>Q9H4Y1</accession>
<accession>Q9H8D3</accession>
<accession>Q9ULE9</accession>
<name>MAVS_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="61">Mitochondrial antiviral-signaling protein</fullName>
<shortName evidence="61">MAVS</shortName>
</recommendedName>
<alternativeName>
<fullName>CARD adapter inducing interferon beta</fullName>
<shortName>Cardif</shortName>
</alternativeName>
<alternativeName>
<fullName>Interferon beta promoter stimulator protein 1</fullName>
<shortName>IPS-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Putative NF-kappa-B-activating protein 031N</fullName>
</alternativeName>
<alternativeName>
<fullName>Virus-induced-signaling adapter</fullName>
<shortName>VISA</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="62">MAVS</name>
<name type="synonym">IPS1</name>
<name type="synonym">KIAA1271</name>
<name type="synonym">VISA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2005" name="Cell" volume="122" first="669" last="682">
<title>Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.</title>
<authorList>
<person name="Seth R.B."/>
<person name="Sun L."/>
<person name="Ea C.-K."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="16125763"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.08.012"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF THR-54 AND 67-GLY--VAL-69</scope>
<scope>INTERACTION WITH DDX58/RIG-I AND TRAF6</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS LYS-198 AND PHE-409</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="727" last="740">
<title>VISA is an adapter protein required for virus-triggered IFN-beta Signaling.</title>
<authorList>
<person name="Xu L.-G."/>
<person name="Wang Y.-Y."/>
<person name="Han K.-J."/>
<person name="Li L.-Y."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="16153868"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.08.014"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH DDX58/RIG-I; IRF3; TRAF2 AND TRAF6</scope>
<scope>MUTAGENESIS OF GLN-145; GLU-155 AND GLU-457</scope>
<scope>FUNCTION</scope>
<scope>VARIANT GLU-93</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="437" first="1167" last="1172">
<title>Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.</title>
<authorList>
<person name="Meylan E."/>
<person name="Curran J."/>
<person name="Hofmann K."/>
<person name="Moradpour D."/>
<person name="Binder M."/>
<person name="Bartenschlager R."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="16177806"/>
<dbReference type="DOI" id="10.1038/nature04193"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH DDX58/RIG-I; IKBKE; CHUK AND IKBKB</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-508</scope>
<scope>VARIANTS LYS-198 AND PHE-409</scope>
<scope>INTERACTION WITH HCV NS3/4A PROTEASE (MICROBIAL INFECTION)</scope>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nat. Immunol." volume="6" first="981" last="988">
<title>IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.</title>
<authorList>
<person name="Kawai T."/>
<person name="Takahashi K."/>
<person name="Sato S."/>
<person name="Coban C."/>
<person name="Kumar H."/>
<person name="Kato H."/>
<person name="Ishii K.J."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="16127453"/>
<dbReference type="DOI" id="10.1038/ni1243"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH DDX58/RIG-I; IFIH1/MDA5; FADD AND RIPK1</scope>
<scope>FUNCTION</scope>
<scope>VARIANT GLU-93</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="Mol. Immunol." volume="45" first="2277" last="2287">
<title>Identification of MAVS splicing variants that interfere with RIGI/MAVS pathway signaling.</title>
<authorList>
<person name="Lad S.P."/>
<person name="Yang G."/>
<person name="Scott D.A."/>
<person name="Chao T.H."/>
<person name="Correia Jda S."/>
<person name="de la Torre J.C."/>
<person name="Li E."/>
</authorList>
<dbReference type="PubMed" id="18207245"/>
<dbReference type="DOI" id="10.1016/j.molimm.2007.11.018"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 6)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2012" name="PLoS Biol." volume="10" first="E1001282" last="E1001282">
<title>Convergent evolution of escape from hepaciviral antagonism in primates.</title>
<authorList>
<person name="Patel M.R."/>
<person name="Loo Y.M."/>
<person name="Horner S.M."/>
<person name="Gale M. Jr."/>
<person name="Malik H.S."/>
</authorList>
<dbReference type="PubMed" id="22427742"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1001282"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="DNA Res." volume="6" first="337" last="345">
<title>Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Kikuno R."/>
<person name="Hirosawa M."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10574462"/>
<dbReference type="DOI" id="10.1093/dnares/6.5.337"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="3307" last="3318">
<title>Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.</title>
<authorList>
<person name="Matsuda A."/>
<person name="Suzuki Y."/>
<person name="Honda G."/>
<person name="Muramatsu S."/>
<person name="Matsuzaki O."/>
<person name="Nagano Y."/>
<person name="Doi T."/>
<person name="Shimotohno K."/>
<person name="Harada T."/>
<person name="Nishida E."/>
<person name="Hayashi H."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="12761501"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung fibroblast</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3; 4 AND 5)</scope>
<scope>VARIANT GLU-93</scope>
<source>
<tissue>Pericardium</tissue>
<tissue>Placenta</tissue>
<tissue>Tongue</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS GLU-93; LYS-198 AND PHE-409</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="17717" last="17722">
<title>Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.</title>
<authorList>
<person name="Li X.D."/>
<person name="Sun L."/>
<person name="Seth R.B."/>
<person name="Pineda G."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="16301520"/>
<dbReference type="DOI" id="10.1073/pnas.0508531102"/>
</citation>
<scope>INTERACTION WITH HCV NS3/4A PROTEASE (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF CYS-435; CYS-452 AND CYS-508</scope>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="J. Virol." volume="80" first="12332" last="12342">
<title>RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2.</title>
<authorList>
<person name="Komuro A."/>
<person name="Horvath C.M."/>
</authorList>
<dbReference type="PubMed" id="17020950"/>
<dbReference type="DOI" id="10.1128/jvi.01325-06"/>
</citation>
<scope>INTERACTION WITH DHX58/LGP2 AND IKBKE</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="J. Virol." volume="81" first="964" last="976">
<title>GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.</title>
<authorList>
<person name="Chen Z."/>
<person name="Benureau Y."/>
<person name="Rijnbrand R."/>
<person name="Yi J."/>
<person name="Wang T."/>
<person name="Warter L."/>
<person name="Lanford R.E."/>
<person name="Weinman S.A."/>
<person name="Lemon S.M."/>
<person name="Martin A."/>
<person name="Li K."/>
</authorList>
<dbReference type="PubMed" id="17093192"/>
<dbReference type="DOI" id="10.1128/jvi.02076-06"/>
</citation>
<scope>INTERACTION WITH HEPATITIS GB VIRUS B NS3/4A PROTEASE (MICROBIAL INFECTION)</scope>
<scope>CLEAVAGE SITE</scope>
<scope>MUTAGENESIS OF CYS-508</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="7253" last="7258">
<title>Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.</title>
<authorList>
<person name="Yang Y."/>
<person name="Liang Y."/>
<person name="Qu L."/>
<person name="Chen Z."/>
<person name="Yi M."/>
<person name="Li K."/>
<person name="Lemon S.M."/>
</authorList>
<dbReference type="PubMed" id="17438296"/>
<dbReference type="DOI" id="10.1073/pnas.0611506104"/>
</citation>
<scope>CLEAVAGE BY HAV PROTEIN 3CD (MICROBIAL INFECTION)</scope>
<scope>CLEAVAGE SITE</scope>
<scope>MUTAGENESIS OF GLN-427 AND GLU-463</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="7500" last="7505">
<title>Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.</title>
<authorList>
<person name="Arimoto K."/>
<person name="Takahashi H."/>
<person name="Hishiki T."/>
<person name="Konishi H."/>
<person name="Fujita T."/>
<person name="Shimotohno K."/>
</authorList>
<dbReference type="PubMed" id="17460044"/>
<dbReference type="DOI" id="10.1073/pnas.0611551104"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="11706" last="11711">
<title>Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase.</title>
<authorList>
<person name="Diao F."/>
<person name="Li S."/>
<person name="Tian Y."/>
<person name="Zhang M."/>
<person name="Xu L.G."/>
<person name="Zhang Y."/>
<person name="Wang R.P."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Zhong B."/>
<person name="Tien P."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="17600090"/>
<dbReference type="DOI" id="10.1073/pnas.0700544104"/>
</citation>
<scope>INTERACTION WITH IFIH1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="14050" last="14055">
<title>The Atg5-Atg12 conjugate associates with innate antiviral immune responses.</title>
<authorList>
<person name="Jounai N."/>
<person name="Takeshita F."/>
<person name="Kobiyama K."/>
<person name="Sawano A."/>
<person name="Miyawaki A."/>
<person name="Xin K.Q."/>
<person name="Ishii K.J."/>
<person name="Kawai T."/>
<person name="Akira S."/>
<person name="Suzuki K."/>
<person name="Okuda K."/>
</authorList>
<dbReference type="PubMed" id="17709747"/>
<dbReference type="DOI" id="10.1073/pnas.0704014104"/>
</citation>
<scope>INTERACTION WITH ATG5 AND ATG12</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-54</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="EMBO Rep." volume="9" first="930" last="936">
<title>The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.</title>
<authorList>
<person name="Friedman C.S."/>
<person name="O'Donnell M.A."/>
<person name="Legarda-Addison D."/>
<person name="Ng A."/>
<person name="Cardenas W.B."/>
<person name="Yount J.S."/>
<person name="Moran T.M."/>
<person name="Basler C.F."/>
<person name="Komuro A."/>
<person name="Horvath C.M."/>
<person name="Xavier R."/>
<person name="Ting A.T."/>
</authorList>
<dbReference type="PubMed" id="18636086"/>
<dbReference type="DOI" id="10.1038/embor.2008.136"/>
</citation>
<scope>INTERACTION WITH CYLD</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Nature" volume="451" first="573" last="577">
<title>NLRX1 is a regulator of mitochondrial antiviral immunity.</title>
<authorList>
<person name="Moore C.B."/>
<person name="Bergstralh D.T."/>
<person name="Duncan J.A."/>
<person name="Lei Y."/>
<person name="Morrison T.E."/>
<person name="Zimmermann A.G."/>
<person name="Accavitti-Loper M.A."/>
<person name="Madden V.J."/>
<person name="Sun L."/>
<person name="Ye Z."/>
<person name="Lich J.D."/>
<person name="Heise M.T."/>
<person name="Chen Z."/>
<person name="Ting J.P.-Y."/>
</authorList>
<dbReference type="PubMed" id="18200010"/>
<dbReference type="DOI" id="10.1038/nature06501"/>
</citation>
<scope>INTERACTION WITH NLRX1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152; SER-157; SER-165; SER-222; SER-233; THR-234 AND SER-258</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Cell" volume="138" first="576" last="591">
<title>RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.</title>
<authorList>
<person name="Chiu Y.-H."/>
<person name="Macmillan J.B."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="19631370"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.06.015"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="19122" last="19131">
<title>The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling.</title>
<authorList>
<person name="Johnsen I.B."/>
<person name="Nguyen T.T."/>
<person name="Bergstroem B."/>
<person name="Fitzgerald K.A."/>
<person name="Anthonsen M.W."/>
</authorList>
<dbReference type="PubMed" id="19419966"/>
<dbReference type="DOI" id="10.1074/jbc.m808233200"/>
</citation>
<scope>INTERACTION WITH SRC</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="J. Immunol." volume="183" first="4241" last="4248">
<title>Negative regulation of MAVS-mediated innate immune response by PSMA7.</title>
<authorList>
<person name="Jia Y."/>
<person name="Song T."/>
<person name="Wei C."/>
<person name="Ni C."/>
<person name="Zheng Z."/>
<person name="Xu Q."/>
<person name="Ma H."/>
<person name="Li L."/>
<person name="Zhang Y."/>
<person name="He X."/>
<person name="Xu Y."/>
<person name="Shi W."/>
<person name="Zhong H."/>
</authorList>
<dbReference type="PubMed" id="19734229"/>
<dbReference type="DOI" id="10.4049/jimmunol.0901646"/>
</citation>
<scope>INTERACTION WITH PSMA7</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Nat. Immunol." volume="10" first="1300" last="1308">
<title>PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.</title>
<authorList>
<person name="You F."/>
<person name="Sun H."/>
<person name="Zhou X."/>
<person name="Sun W."/>
<person name="Liang S."/>
<person name="Zhai Z."/>
<person name="Jiang Z."/>
</authorList>
<dbReference type="PubMed" id="19881509"/>
<dbReference type="DOI" id="10.1038/ni.1815"/>
</citation>
<scope>INTERACTION WITH PCBP2</scope>
<scope>UBIQUITINATION BY ITCH</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="1530" last="1535">
<title>Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria.</title>
<authorList>
<person name="Xu L."/>
<person name="Xiao N."/>
<person name="Liu F."/>
<person name="Ren H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="19164550"/>
<dbReference type="DOI" id="10.1073/pnas.0811029106"/>
</citation>
<scope>INTERACTION WITH C1QBP</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="7945" last="7950">
<title>ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response.</title>
<authorList>
<person name="Li Y."/>
<person name="Li C."/>
<person name="Xue P."/>
<person name="Zhong B."/>
<person name="Mao A.P."/>
<person name="Ran Y."/>
<person name="Chen H."/>
<person name="Wang Y.Y."/>
<person name="Yang F."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="19416887"/>
<dbReference type="DOI" id="10.1073/pnas.0900818106"/>
</citation>
<scope>INTERACTION WITH STING1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152 AND SER-165</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Cell" volume="141" first="668" last="681">
<title>Peroxisomes are signaling platforms for antiviral innate immunity.</title>
<authorList>
<person name="Dixit E."/>
<person name="Boulant S."/>
<person name="Zhang Y."/>
<person name="Lee A.S."/>
<person name="Odendall C."/>
<person name="Shum B."/>
<person name="Hacohen N."/>
<person name="Chen Z.J."/>
<person name="Whelan S.P."/>
<person name="Fransen M."/>
<person name="Nibert M.L."/>
<person name="Superti-Furga G."/>
<person name="Kagan J.C."/>
</authorList>
<dbReference type="PubMed" id="20451243"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.04.018"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Eur. J. Immunol." volume="40" first="940" last="948">
<title>DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.</title>
<authorList>
<person name="Oshiumi H."/>
<person name="Sakai K."/>
<person name="Matsumoto M."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="20127681"/>
<dbReference type="DOI" id="10.1002/eji.200940203"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DDX3X</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E14258" last="E14258">
<title>Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction.</title>
<authorList>
<person name="Oshiumi H."/>
<person name="Ikeda M."/>
<person name="Matsumoto M."/>
<person name="Watanabe A."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
<person name="Kato N."/>
<person name="Shimotohno K."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="21170385"/>
<dbReference type="DOI" id="10.1371/journal.pone.0014258"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DDX3X</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253 AND SER-258</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="PLoS Pathog." volume="7" first="E1001311" last="E1001311">
<title>The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling.</title>
<authorList>
<person name="Mukherjee A."/>
<person name="Morosky S.A."/>
<person name="Delorme-Axford E."/>
<person name="Dybdahl-Sissoko N."/>
<person name="Oberste M.S."/>
<person name="Wang T."/>
<person name="Coyne C.B."/>
</authorList>
<dbReference type="PubMed" id="21436888"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1001311"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF GLN-148</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="J. Immunol." volume="187" first="2559" last="2568">
<title>IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1.</title>
<authorList>
<person name="Liu X.Y."/>
<person name="Chen W."/>
<person name="Wei B."/>
<person name="Shan Y.F."/>
<person name="Wang C."/>
</authorList>
<dbReference type="PubMed" id="21813773"/>
<dbReference type="DOI" id="10.4049/jimmunol.1100963"/>
</citation>
<scope>INTERACTION WITH IFIT3 AND TBK1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="J. Immunol." volume="189" first="5304" last="5313">
<title>Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation.</title>
<authorList>
<person name="Wang Y."/>
<person name="Tong X."/>
<person name="Ye X."/>
</authorList>
<dbReference type="PubMed" id="23087404"/>
<dbReference type="DOI" id="10.4049/jimmunol.1201445"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NDFIP1 AND SMURF1</scope>
<scope>UBIQUITINATION BY SMURF1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E29386" last="E29386">
<title>Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection.</title>
<authorList>
<person name="Boyapalle S."/>
<person name="Wong T."/>
<person name="Garay J."/>
<person name="Teng M."/>
<person name="San Juan-Vergara H."/>
<person name="Mohapatra S."/>
<person name="Mohapatra S."/>
</authorList>
<dbReference type="PubMed" id="22383950"/>
<dbReference type="DOI" id="10.1371/journal.pone.0029386"/>
</citation>
<scope>INTERACTION WITH HRSV NS1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="FEBS Lett." volume="587" first="2137" last="2142">
<title>A role for the Ankyrin repeat containing protein Ankrd17 in Nod1- and Nod2-mediated inflammatory responses.</title>
<authorList>
<person name="Menning M."/>
<person name="Kufer T.A."/>
</authorList>
<dbReference type="PubMed" id="23711367"/>
<dbReference type="DOI" id="10.1016/j.febslet.2013.05.037"/>
</citation>
<scope>INTERACTION WITH ANKRD17</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="Immunol. Cell Biol." volume="91" first="321" last="330">
<title>Mitochondrially localised MUL1 is a novel modulator of antiviral signaling.</title>
<authorList>
<person name="Jenkins K."/>
<person name="Khoo J.J."/>
<person name="Sadler A."/>
<person name="Piganis R."/>
<person name="Wang D."/>
<person name="Borg N.A."/>
<person name="Hjerrild K."/>
<person name="Gould J."/>
<person name="Thomas B.J."/>
<person name="Nagley P."/>
<person name="Hertzog P.J."/>
<person name="Mansell A."/>
</authorList>
<dbReference type="PubMed" id="23399697"/>
<dbReference type="DOI" id="10.1038/icb.2013.7"/>
</citation>
<scope>INTERACTION WITH MUL1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="1057" last="1070">
<title>UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS.</title>
<authorList>
<person name="Wang P."/>
<person name="Yang L."/>
<person name="Cheng G."/>
<person name="Yang G."/>
<person name="Xu Z."/>
<person name="You F."/>
<person name="Sun Q."/>
<person name="Lin R."/>
<person name="Fikrig E."/>
<person name="Sutton R.E."/>
</authorList>
<dbReference type="PubMed" id="23545497"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.02.027"/>
</citation>
<scope>INTERACTION WITH UBXN1</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152; SER-165; SER-180; SER-188; THR-215 AND SER-222</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2014" name="J. Virol." volume="88" first="3369" last="3378">
<title>Enterovirus 2Apro targets MDA5 and MAVS in infected cells.</title>
<authorList>
<person name="Feng Q."/>
<person name="Langereis M.A."/>
<person name="Lork M."/>
<person name="Nguyen M."/>
<person name="Hato S.V."/>
<person name="Lanke K."/>
<person name="Emdad L."/>
<person name="Bhoopathi P."/>
<person name="Fisher P.B."/>
<person name="Lloyd R.E."/>
<person name="van Kuppeveld F.J."/>
</authorList>
<dbReference type="PubMed" id="24390337"/>
<dbReference type="DOI" id="10.1128/jvi.02712-13"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2014" name="J. Immunol." volume="193" first="3080" last="3089">
<title>SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.</title>
<authorList>
<person name="Shi C.S."/>
<person name="Qi H.Y."/>
<person name="Boularan C."/>
<person name="Huang N.N."/>
<person name="Abu-Asab M."/>
<person name="Shelhamer J.H."/>
<person name="Kehrl J.H."/>
</authorList>
<dbReference type="PubMed" id="25135833"/>
<dbReference type="DOI" id="10.4049/jimmunol.1303196"/>
</citation>
<scope>INTERACTION WITH SARS-COV VIRUS PROTEIN ORF9B (MICROBIAL INFECTION)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2015" name="Science" volume="347" first="AAA2630" last="AAA2630">
<title>Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.</title>
<authorList>
<person name="Liu S."/>
<person name="Cai X."/>
<person name="Wu J."/>
<person name="Cong Q."/>
<person name="Chen X."/>
<person name="Li T."/>
<person name="Du F."/>
<person name="Ren J."/>
<person name="Wu Y.T."/>
<person name="Grishin N.V."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="25636800"/>
<dbReference type="DOI" id="10.1126/science.aaa2630"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>INTERACTION WITH IRF3</scope>
<scope>PHOSPHORYLATION AT SER-442</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-442</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2017" name="Biochem. J." volume="474" first="571" last="587">
<title>DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.</title>
<authorList>
<person name="Gu L."/>
<person name="Fullam A."/>
<person name="McCormack N."/>
<person name="Hoehn Y."/>
<person name="Schroeder M."/>
</authorList>
<dbReference type="PubMed" id="27980081"/>
<dbReference type="DOI" id="10.1042/bcj20160956"/>
</citation>
<scope>INTERACTION WITH DDX3X AND TRAF3</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2017" name="J. Immunol." volume="198" first="1274" last="1284">
<title>TTLL12 Inhibits the Activation of Cellular Antiviral Signaling through Interaction with VISA/MAVS.</title>
<authorList>
<person name="Ju L.G."/>
<person name="Zhu Y."/>
<person name="Lei P.J."/>
<person name="Yan D."/>
<person name="Zhu K."/>
<person name="Wang X."/>
<person name="Li Q.L."/>
<person name="Li X.J."/>
<person name="Chen J.W."/>
<person name="Li L.Y."/>
<person name="Wu M."/>
</authorList>
<dbReference type="PubMed" id="28011935"/>
<dbReference type="DOI" id="10.4049/jimmunol.1601194"/>
</citation>
<scope>INTERACTION WITH TTLL12; TBK1 AND IKBKE</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2017" name="J. Virol." volume="91">
<title>Seneca Valley virus suppresses host type I interferon production by targeting adaptor proteins MAVS, TRIF, and TANK for cleavage.</title>
<authorList>
<person name="Qian S."/>
<person name="Fan W."/>
<person name="Liu T."/>
<person name="Wu M."/>
<person name="Zhang H."/>
<person name="Cui X."/>
<person name="Zhou Y."/>
<person name="Hu J."/>
<person name="Wei S."/>
<person name="Chen H."/>
<person name="Li X."/>
<person name="Qian P."/>
</authorList>
<dbReference type="PubMed" id="28566380"/>
<dbReference type="DOI" id="10.1128/jvi.00823-17"/>
</citation>
<scope>INTERACTION WITH SENECA VALLEY VIRUS PROTEASE 3C (MICROBIAL INFECTION)</scope>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF GLN-148; GLN-159; GLN-162; GLN-196 AND GLN-198</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2017" name="PLoS Pathog." volume="13" first="E1006243" last="E1006243">
<title>Correction: Enterovirus 71 Protease 2Apro Targets MAVS to Inhibit Anti-Viral Type I Interferon Responses.</title>
<authorList>
<person name="Wang B."/>
<person name="Xi X."/>
<person name="Lei X."/>
<person name="Zhang X."/>
<person name="Cui S."/>
<person name="Wang J."/>
<person name="Jin Q."/>
<person name="Zhao Z."/>
</authorList>
<dbReference type="PubMed" id="28253362"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1006243"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2017" name="PLoS Pathog." volume="13" first="E1006328" last="E1006328">
<title>GPATCH3 negatively regulates RLR-mediated innate antiviral responses by disrupting the assembly of VISA signalosome.</title>
<authorList>
<person name="Nie Y."/>
<person name="Ran Y."/>
<person name="Zhang H.Y."/>
<person name="Huang Z.F."/>
<person name="Pan Z.Y."/>
<person name="Wang S.Y."/>
<person name="Wang Y.Y."/>
</authorList>
<dbReference type="PubMed" id="28414768"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1006328"/>
</citation>
<scope>INTERACTION WITH GPATCH3</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2019" name="IScience" volume="19" first="1065" last="1078">
<title>Structural Basis of Mitochondrial Scaffolds by Prohibitin Complexes: Insight into a Role of the Coiled-Coil Region.</title>
<authorList>
<person name="Yoshinaka T."/>
<person name="Kosako H."/>
<person name="Yoshizumi T."/>
<person name="Furukawa R."/>
<person name="Hirano Y."/>
<person name="Kuge O."/>
<person name="Tamada T."/>
<person name="Koshiba T."/>
</authorList>
<dbReference type="PubMed" id="31522117"/>
<dbReference type="DOI" id="10.1016/j.isci.2019.08.056"/>
</citation>
<scope>INTERACTION WITH CLPB</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2014" name="Elife" volume="3" first="E01489" last="E01489">
<title>Structural basis for the prion-like MAVS filaments in antiviral innate immunity.</title>
<authorList>
<person name="Xu H."/>
<person name="He X."/>
<person name="Zheng H."/>
<person name="Huang L.J."/>
<person name="Hou F."/>
<person name="Yu Z."/>
<person name="de la Cruz M.J."/>
<person name="Borkowski B."/>
<person name="Zhang X."/>
<person name="Chen Z.J."/>
<person name="Jiang Q.X."/>
</authorList>
<dbReference type="PubMed" id="24569476"/>
<dbReference type="DOI" id="10.7554/elife.01489"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (9.6 ANGSTROMS) OF 3-93</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF GLU-26 AND TRP-56</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2014" name="Mol. Cell" volume="55" first="511" last="523">
<title>Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I.</title>
<authorList>
<person name="Wu B."/>
<person name="Peisley A."/>
<person name="Tetrault D."/>
<person name="Li Z."/>
<person name="Egelman E.H."/>
<person name="Magor K.E."/>
<person name="Walz T."/>
<person name="Penczek P.A."/>
<person name="Hur S."/>
</authorList>
<dbReference type="PubMed" id="25018021"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.06.010"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 1-99 IN COMPLEX WITH DDX58/RIG-I</scope>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.64 ANGSTROMS) OF 1-97</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="60" evidence="5">
<citation type="journal article" date="2016" name="Proc. Natl. Acad. Sci. U.S.A." volume="113" first="E3403" last="E3412">
<title>Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins.</title>
<authorList>
<person name="Zhao B."/>
<person name="Shu C."/>
<person name="Gao X."/>
<person name="Sankaran B."/>
<person name="Du F."/>
<person name="Shelton C.L."/>
<person name="Herr A.B."/>
<person name="Ji J.Y."/>
<person name="Li P."/>
</authorList>
<dbReference type="PubMed" id="27302953"/>
<dbReference type="DOI" id="10.1073/pnas.1603269113"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 433-450 IN COMPLEX WITH IRF3</scope>
<scope>INTERACTION WITH IRF3</scope>
<scope>PHOSPHORYLATION AT SER-442</scope>
<scope>MUTAGENESIS OF SER-442</scope>
</reference>
<comment type="function">
<text evidence="18 19 20 21 34 37 38 39 43 51">Required for innate immune defense against viruses (PubMed:16125763, PubMed:16127453, PubMed:16153868, PubMed:16177806, PubMed:19631370, PubMed:20451243, PubMed:23087404, PubMed:20127681, PubMed:21170385). Acts downstream of DHX33, DDX58/RIG-I and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5) (PubMed:16125763, PubMed:16127453, PubMed:16153868, PubMed:16177806, PubMed:19631370, PubMed:20451243, PubMed:23087404, PubMed:25636800, PubMed:20127681, PubMed:21170385). Peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state (PubMed:20451243). Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response (PubMed:20451243). May activate the same pathways following detection of extracellular dsRNA by TLR3 (PubMed:16153868). May protect cells from apoptosis (PubMed:16125763).</text>
</comment>
<comment type="subunit">
<text evidence="12 13 18 19 20 21 23 27 28 29 30 31 32 33 35 36 37 39 41 43 44 45 46 48 49 51 52 53 54 56 58">Self-associates and polymerizes (via CARD domains) to form 400 nM long three-stranded helical filaments on mitochondria, filament nucleation requires interaction with DDX58/RIG-I whose CARD domains act as a template for filament assembly (PubMed:24569476, PubMed:25018021). Interacts with DDX58/RIG-I, IFIH1/MDA5, TRAF2, TRAF6 and C1QBP (PubMed:16125763, PubMed:16127453, PubMed:17600090). May interact with FADD, RIPK1, CHUK and IKBKB (PubMed:16153868, PubMed:16177806, PubMed:16127453). Interacts (when phosphorylated) with IRF3; following activation and phosphorylation on the pLxIS motif by TBK1, recruits IRF3 (PubMed:25636800, PubMed:27302953). Interacts with NLRX1 (PubMed:18200010). Interaction with NLRX1 requires the CARD domain (PubMed:18200010). Interacts with PSMA7 (PubMed:19734229). Interacts with TRAFD1 (By similarity). Interacts (via C-terminus) with PCBP2 in a complex containing MAVS/IPS1, PCBP2 and ITCH (PubMed:19881509). Interacts with CYLD (PubMed:18636086). Interacts with SRC (PubMed:19419966). Interacts with DHX58/LGP2 and IKBKE (PubMed:16177806, PubMed:17020950, PubMed:28011935). Interacts with STING1 (PubMed:19416887). Interacts with IFIT3 (via N-terminus) (PubMed:21813773). Interacts with TBK1 only in the presence of IFIT3 (PubMed:21813773, PubMed:28011935). Interacts with TTLL12; the interaction prevents MAVS binding to TBK1 and IKBKE (PubMed:28011935). Interacts with MUL1 (PubMed:23399697). Interacts with ANKRD17 (PubMed:23711367). Interacts with NDFIP1 (PubMed:23087404). Interacts with SMURF1; the interaction is mediated by NDFIP1 and leads to MAVS ubiquitination and degradation (PubMed:23087404). Interacts with UBXN1; this interaction inhibits MAVS-mediated antiviral pathway (PubMed:23545497). Interacts (via C-terminus) with GPATCH3; the interaction is markedly increased upon viral infection (PubMed:28414768). Directly interacts (via CARD domain) with ATG5 and ATG12, either as ATG5 and ATG12 monomers or as ATG12-ATG5 conjugates (PubMed:17709747). Interacts with DHX33 (via the helicase C-terminal domain) (By similarity). Interacts with DDX3X (via C-terminus); this interaction occurs rapidly, but transiently after Sendai virus infection (PubMed:20127681, PubMed:21170385, PubMed:27980081). The interaction with DDX3X potentiates MAVS-mediated IFNB induction (PubMed:20127681). Conversely inhibition of this interaction, for instance by HCV core protein, prevents MAVS-mediated IFNB induction (PubMed:21170385). Transiently interacts with TRAF3 early during Sendai virus infection (PubMed:27980081). Interacts with CLPB; the interaction is enhanced by Sendai virus infection (PubMed:31522117).</text>
</comment>
<comment type="subunit">
<text evidence="21 22">(Microbial infection) Interacts with hepatitis C virus (HCV) NS3/4A protease; this interaction leads to MAVS cleavage, thereby preventing the establishment of an antiviral state.</text>
</comment>
<comment type="subunit">
<text evidence="24">(Microbial infection) Interacts with hepatitis GB virus B NS3/4A protease; this interaction leads to MAVS cleavage.</text>
</comment>
<comment type="subunit">
<text evidence="42">(Microbial infection) Interacts with human respiratory syncytial virus/HRSV protein NS1; this interaction disrupts MAVS binding to DDX58/RIG-I.</text>
</comment>
<comment type="subunit">
<text evidence="57">(Microbial infection) Interacts with Seneca Valley virus protease 3C; this interaction allows the cleavage of MAVS and subsequent suppression of host innate immunity.</text>
</comment>
<comment type="subunit">
<text evidence="50">(Microbial infection) Interacts with SARS-CoV virus protein ORF9b; this interaction mediates MAVS proteasomal degradation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-347552">
<id>P46379</id>
<label>BAG6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-347528">
<id>Q07021</id>
<label>C1QBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-739580">
<id>Q13137</id>
<label>CALCOCO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-353779">
<id>O00571</id>
<label>DDX3X</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-995350">
<id>O95786</id>
<label>DDX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-6115771">
<id>Q9BYX4</id>
<label>IFIH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-307369">
<id>Q14164</id>
<label>IKBKE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-3931258">
<id>Q13568</id>
<label>IRF5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-751501">
<id>Q9Y2W7</id>
<label>KCNIP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-1048197">
<id>Q8IWA4</id>
<label>MFN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-6253230">
<id>Q96P20</id>
<label>NLRP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-6115729">
<id>Q9Y6K5</id>
<label>OAS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-358522">
<id>O43353</id>
<label>RIPK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-2800345">
<id>Q86WV6</id>
<label>STING1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
<label>TBK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-359276">
<id>Q9Y4K3</id>
<label>TRAF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-1048119">
<id>Q14139</id>
<label>UBE4A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-25492846">
<id>Q7TFA1</id>
<label>7b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-9021274">
<id>P59636</id>
<label>9b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-6863628">
<id>Q6WB96</id>
<label>M2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-3650820">
<id>Q69027</id>
<label>X</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-9522123">
<id>A2T3M4</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
</interactant>
<interactant intactId="EBI-25475914">
<id>P0DTD8</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-1047414">
<id>Q9H1Y0</id>
<label>ATG5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-15577823">
<id>O95786-1</id>
<label>DDX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-6115771">
<id>Q9BYX4</id>
<label>IFIH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-15680006">
<id>Q86UT6-1</id>
<label>NLRX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-2339208">
<id>Q96EQ8</id>
<label>RNF125</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-2800345">
<id>Q86WV6</id>
<label>STING1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-540834">
<id>P61964</id>
<label>WDR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
</interactant>
<interactant intactId="EBI-16182226">
<id>Q91WS2-1</id>
<label>Nlrp6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="18">Mitochondrion outer membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15 28 37 39 50">Mitochondrion</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="38">Peroxisome</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q7Z434-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q7Z434-2</id>
<name>2</name>
<sequence type="described" ref="VSP_010262 VSP_010263"/>
</isoform>
<isoform>
<id>Q7Z434-3</id>
<name>3</name>
<sequence type="described" ref="VSP_010261 VSP_010264"/>
</isoform>
<isoform>
<id>Q7Z434-4</id>
<name>4</name>
<sequence type="described" ref="VSP_045872"/>
</isoform>
<isoform>
<id>Q7Z434-5</id>
<name>5</name>
<name>MAVS1b</name>
<name>exon 3 deletion</name>
<sequence type="described" ref="VSP_047817 VSP_047818"/>
</isoform>
<isoform>
<id>Q7Z434-6</id>
<name>6</name>
<name>MAVS1a</name>
<name>exon 2 deletion</name>
<sequence type="described" ref="VSP_047816 VSP_010263"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="18 19 20">Present in T-cells, monocytes, epithelial cells and hepatocytes (at protein level). Ubiquitously expressed, with highest levels in heart, skeletal muscle, liver, placenta and peripheral blood leukocytes.</text>
</comment>
<comment type="domain">
<text evidence="51">The pLxIS motif constitutes an IRF3-binding motif: following phosphorylation by TBK1, the phosphorylated pLxIS motif of MAVS recruits IRF3 (PubMed:25636800). IRF3 is then phosphorylated and activated by TBK1 to induce type-I interferons and other cytokines (PubMed:25636800).</text>
</comment>
<comment type="domain">
<text evidence="18">Both CARD and transmembrane domains are essential for antiviral function. The CARD domain is responsible for interaction with DDX58/RIG-I and IFIH1/MDA5.</text>
</comment>
<comment type="domain">
<text evidence="23">The transmembrane domain and residues 300-444 are essential for its interaction with DHX58/LGP2.</text>
</comment>
<comment type="PTM">
<text evidence="51 52">Following activation, phosphorylated by TBK1 at Ser-442 in the pLxIS motif (PubMed:25636800, PubMed:27302953). The phosphorylated pLxIS motif constitutes an IRF3-binding motif, leading to recruitment of the transcription factor IRF3 to induce type-I interferons and other cytokines (PubMed:25636800).</text>
</comment>
<comment type="PTM">
<text evidence="25">(Microbial infection) Cleaved and degraded by hepatitis A virus (HAV) protein 3ABC allowing the virus to disrupt the activation of host IRF3 through the MDA5 pathway.</text>
</comment>
<comment type="PTM">
<text evidence="47 55">(Microbial infection) Cleaved by the protease 2A of coxsackievirus B3, poliovirus and enterovirus 71 allowing the virus to disrupt the host type I interferon production.</text>
</comment>
<comment type="PTM">
<text evidence="26 36 43 51">Ubiquitinated (PubMed:19881509, PubMed:23087404, PubMed:25636800). Undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH; ITCH-dependent polyubiquitination is mediated by the interaction with PCBP2 and leads to MAVS/IPS1 proteasomal degradation (PubMed:19881509). Ubiquitinated by RNF125, leading to its degradation by the proteasome (PubMed:17460044). Undergoes 'Lys-48'-linked ubiquitination catalyzed by SMURF1 (PubMed:23087404).</text>
</comment>
<comment type="PTM">
<text evidence="57">(Microbial infection) Cleaved by Seneca Valley virus protease 3C allowing the virus to suppress interferon type-I production.</text>
</comment>
<comment type="PTM">
<text evidence="21 22">(Microbial infection) Cleaved by HCV protease NS3/4A, thereby preventing the establishment of an antiviral state.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 5</molecule>
<text evidence="61">Selectively activates an IFNbeta but not an IL8 promoter. Interacts with RIP1 and FADD and exhibits anti-viral activity against VSV infection.</text>
</comment>
<comment type="sequence caution" evidence="61">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA86585" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="61">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="BAB14684" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="DQ174270">
<property type="protein sequence ID" value="AAZ80417.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ167126">
<property type="protein sequence ID" value="ABA54890.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ181928">
<property type="protein sequence ID" value="ABA19229.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB232371">
<property type="protein sequence ID" value="BAE79738.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF467323">
<property type="protein sequence ID" value="ABR24161.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF467324">
<property type="protein sequence ID" value="ABR24162.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="KC415005">
<property type="protein sequence ID" value="AGF94754.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB033097">
<property type="protein sequence ID" value="BAA86585.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB097003">
<property type="protein sequence ID" value="BAC77356.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK023799">
<property type="protein sequence ID" value="BAB14684.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK123956">
<property type="protein sequence ID" value="BAC85734.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK130992">
<property type="protein sequence ID" value="BAC85473.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291785">
<property type="protein sequence ID" value="BAF84474.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK296897">
<property type="protein sequence ID" value="BAG59455.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL109804">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353194">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471133">
<property type="protein sequence ID" value="EAX10481.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC044952">
<property type="protein sequence ID" value="AAH44952.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33437.1">
<molecule id="Q7Z434-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56176.1">
<molecule id="Q7Z434-4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001193420.1">
<molecule id="Q7Z434-4"/>
<property type="nucleotide sequence ID" value="NM_001206491.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_065797.2">
<molecule id="Q7Z434-1"/>
<property type="nucleotide sequence ID" value="NM_020746.4"/>
</dbReference>
<dbReference type="PDB" id="2MS7">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U=1-100"/>
</dbReference>
<dbReference type="PDB" id="2MS8">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-100"/>
</dbReference>
<dbReference type="PDB" id="2VGQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-93"/>
</dbReference>
<dbReference type="PDB" id="3J6C">
<property type="method" value="EM"/>
<property type="resolution" value="9.60"/>
<property type="chains" value="A=3-93"/>
</dbReference>
<dbReference type="PDB" id="3J6J">
<property type="method" value="EM"/>
<property type="resolution" value="3.64"/>
<property type="chains" value="A/B/C/D/E/G/I/L=1-97"/>
</dbReference>
<dbReference type="PDB" id="3RC5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="B=502-508"/>
</dbReference>
<dbReference type="PDB" id="4P4H">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="I/J/K/L/M/N/O/P=1-99"/>
</dbReference>
<dbReference type="PDB" id="4Z8M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="C/D=450-468"/>
</dbReference>
<dbReference type="PDB" id="5JEK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C/D=433-448"/>
</dbReference>
<dbReference type="PDBsum" id="2MS7"/>
<dbReference type="PDBsum" id="2MS8"/>
<dbReference type="PDBsum" id="2VGQ"/>
<dbReference type="PDBsum" id="3J6C"/>
<dbReference type="PDBsum" id="3J6J"/>
<dbReference type="PDBsum" id="3RC5"/>
<dbReference type="PDBsum" id="4P4H"/>
<dbReference type="PDBsum" id="4Z8M"/>
<dbReference type="PDBsum" id="5JEK"/>
<dbReference type="BMRB" id="Q7Z434"/>
<dbReference type="SMR" id="Q7Z434"/>
<dbReference type="BioGRID" id="121570">
<property type="interactions" value="140"/>
</dbReference>
<dbReference type="DIP" id="DIP-35445N"/>
<dbReference type="IntAct" id="Q7Z434">
<property type="interactions" value="81"/>
</dbReference>
<dbReference type="MINT" id="Q7Z434"/>
<dbReference type="STRING" id="9606.ENSP00000401980"/>
<dbReference type="GlyGen" id="Q7Z434">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q7Z434"/>
<dbReference type="MetOSite" id="Q7Z434"/>
<dbReference type="PhosphoSitePlus" id="Q7Z434"/>
<dbReference type="SwissPalm" id="Q7Z434"/>
<dbReference type="BioMuta" id="MAVS"/>
<dbReference type="DMDM" id="47115748"/>
<dbReference type="CPTAC" id="CPTAC-977"/>
<dbReference type="EPD" id="Q7Z434"/>
<dbReference type="jPOST" id="Q7Z434"/>
<dbReference type="MassIVE" id="Q7Z434"/>
<dbReference type="MaxQB" id="Q7Z434"/>
<dbReference type="PaxDb" id="Q7Z434"/>
<dbReference type="PeptideAtlas" id="Q7Z434"/>
<dbReference type="PRIDE" id="Q7Z434"/>
<dbReference type="ProteomicsDB" id="27148"/>
<dbReference type="ProteomicsDB" id="3402"/>
<dbReference type="ProteomicsDB" id="69137">
<molecule id="Q7Z434-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="69138">
<molecule id="Q7Z434-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="69139">
<molecule id="Q7Z434-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="3363">
<property type="antibodies" value="641 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="57506"/>
<dbReference type="Ensembl" id="ENST00000416600">
<molecule id="Q7Z434-4"/>
<property type="protein sequence ID" value="ENSP00000413749"/>
<property type="gene ID" value="ENSG00000088888"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000428216">
<molecule id="Q7Z434-1"/>
<property type="protein sequence ID" value="ENSP00000401980"/>
<property type="gene ID" value="ENSG00000088888"/>
</dbReference>
<dbReference type="GeneID" id="57506"/>
<dbReference type="KEGG" id="hsa:57506"/>
<dbReference type="UCSC" id="uc002wjw.5">
<molecule id="Q7Z434-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="57506"/>
<dbReference type="DisGeNET" id="57506"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000088888.17"/>
<dbReference type="GeneCards" id="MAVS"/>
<dbReference type="HGNC" id="HGNC:29233">
<property type="gene designation" value="MAVS"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000088888">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="609676">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q7Z434"/>
<dbReference type="OpenTargets" id="ENSG00000088888"/>
<dbReference type="PharmGKB" id="PA164722208"/>
<dbReference type="eggNOG" id="ENOG502SAUA">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00510000049120"/>
<dbReference type="HOGENOM" id="CLU_042052_0_0_1"/>
<dbReference type="InParanoid" id="Q7Z434"/>
<dbReference type="KO" id="K12648"/>
<dbReference type="OMA" id="HNGYREE"/>
<dbReference type="OrthoDB" id="887440at2759"/>
<dbReference type="PhylomeDB" id="Q7Z434"/>
<dbReference type="TreeFam" id="TF333444"/>
<dbReference type="PathwayCommons" id="Q7Z434"/>
<dbReference type="Reactome" id="R-HSA-168928">
<property type="pathway name" value="DDX58/IFIH1-mediated induction of interferon-alpha/beta"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of DDX58/IFIH1 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q7Z434"/>
<dbReference type="SIGNOR" id="Q7Z434"/>
<dbReference type="BioGRID-ORCS" id="57506">
<property type="hits" value="5 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MAVS">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q7Z434"/>
<dbReference type="GeneWiki" id="VISA_(gene)"/>
<dbReference type="GenomeRNAi" id="57506"/>
<dbReference type="Pharos" id="Q7Z434">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q7Z434"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="RNAct" id="Q7Z434">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000088888">
<property type="expression patterns" value="Expressed in caecum and 240 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q7Z434">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031966">
<property type="term" value="C:mitochondrial membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005741">
<property type="term" value="C:mitochondrial outer membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005778">
<property type="term" value="C:peroxisomal membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050700">
<property type="term" value="F:CARD domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035591">
<property type="term" value="F:signaling adaptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002218">
<property type="term" value="P:activation of innate immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071360">
<property type="term" value="P:cellular response to exogenous dsRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045071">
<property type="term" value="P:negative regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071651">
<property type="term" value="P:positive regulation of chemokine (C-C motif) ligand 5 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002230">
<property type="term" value="P:positive regulation of defense response to virus by host"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0007001"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071660">
<property type="term" value="P:positive regulation of IP-10 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002735">
<property type="term" value="P:positive regulation of myeloid dendritic cell cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060760">
<property type="term" value="P:positive regulation of response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904469">
<property type="term" value="P:positive regulation of tumor necrosis factor secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060340">
<property type="term" value="P:positive regulation of type I interferon-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900063">
<property type="term" value="P:regulation of peroxisome organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd08811">
<property type="entry name" value="CARD_IPS1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031964">
<property type="entry name" value="CARD_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR042144">
<property type="entry name" value="CARD_IPS1"/>
</dbReference>
<dbReference type="InterPro" id="IPR026148">
<property type="entry name" value="Mt_antiviral_sig_pro_met"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR21446:SF6">
<property type="entry name" value="PTHR21446:SF6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16739">
<property type="entry name" value="CARD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-1000">Mitochondrion outer membrane</keyword>
<keyword id="KW-0576">Peroxisome</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Mitochondrial antiviral-signaling protein" id="PRO_0000144096">
<location>
<begin position="1"/>
<end position="540"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="61">
<location>
<begin position="1"/>
<end position="513"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="14">
<location>
<begin position="514"/>
<end position="534"/>
</location>
</feature>
<feature type="topological domain" description="Mitochondrial intermembrane" evidence="61">
<location>
<begin position="535"/>
<end position="540"/>
</location>
</feature>
<feature type="domain" description="CARD">
<location>
<begin position="10"/>
<end position="77"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with NLRX1" evidence="29">
<location>
<begin position="10"/>
<end position="77"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRAF2" evidence="20">
<location>
<begin position="143"/>
<end position="147"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRAF6">
<location>
<begin position="153"/>
<end position="158"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRAF6">
<location>
<begin position="455"/>
<end position="460"/>
</location>
</feature>
<feature type="short sequence motif" description="pLxIS motif" evidence="51">
<location>
<begin position="439"/>
<end position="442"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="103"/>
<end position="153"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage; by viral Seneca Valley virus protease 3C" evidence="57">
<location>
<begin position="148"/>
<end position="149"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage by CV3B" evidence="40">
<location>
<position position="148"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage by protease 2A of enterovirus 71" evidence="55">
<location>
<begin position="208"/>
<end position="209"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage by protease 2A of enterovirus 71" evidence="55">
<location>
<begin position="250"/>
<end position="251"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage by protease 2A of enterovirus 71" evidence="55">
<location>
<begin position="264"/>
<end position="265"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage; by HAV protein 3ABC" evidence="25">
<location>
<begin position="427"/>
<end position="428"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage; by HCV and hepatitis GB virus B NS3/4A protease complex" evidence="21 22">
<location>
<begin position="508"/>
<end position="509"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 11">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="157"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 11">
<location>
<position position="165"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 10 11">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="233"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="13">
<location>
<position position="236"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="253"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 9">
<location>
<position position="258"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="408"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1" evidence="51 52">
<location>
<position position="442"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_045872" evidence="59">
<location>
<begin position="1"/>
<end position="141"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_047816" evidence="60">
<original>DRLRATCTLSGNRDTLWHLFNTLQRRPGWVEYFIAALRGCELVDLADEVASVYQSYQPRTSDRPPDPLEPPSLPAERPGPPTPAAAHSIPYN</original>
<variation>GPRTVPQTHWSHRHFLLRGQGPPHLLRPTASPTTAAERRSQVTPCLSRRPRRQSPQERIQSKPCRRSAPEPSQGIQMVAPWSPPLTWQPSAL</variation>
<location>
<begin position="40"/>
<end position="131"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_010261" evidence="59">
<original>RRPGWVEYFIAALRGCELVDLADEVASVYQSYQPRTSDRPPDPLEPPSLPAERPGPPTPAAAHSIPYNSCREKEPSYPMPVQETQ</original>
<variation>LPTWAGEETPGGQSSGRGLDFSSLTSGAVWLWQMSDFWSCFSTWTVSIWLILHWVLLRLNLQVFAKCLAQSKWPLLLPSLSCPTW</variation>
<location>
<begin position="64"/>
<end position="148"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_047817" evidence="59 60">
<original>RTSDRPPDPLEPPSLPAERPGPPTPAA</original>
<variation>QFRASPADAQPQSHPKESRWWPPGVLL</variation>
<location>
<begin position="98"/>
<end position="124"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_010262" evidence="59">
<original>TSDRPPDPLEPPSLPAERPGPPTPAAAHSIPYN</original>
<variation>ERPALALLDPQPAPWPPLSFSLSLYFLPFSVILFLVTVKR</variation>
<location>
<begin position="99"/>
<end position="131"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_047818" evidence="59 60">
<location>
<begin position="125"/>
<end position="540"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 6." id="VSP_010263" evidence="59 60">
<location>
<begin position="132"/>
<end position="540"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_010264" evidence="59">
<location>
<begin position="149"/>
<end position="540"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11905552." id="VAR_048609">
<original>C</original>
<variation>F</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11908032." id="VAR_059197">
<original>C</original>
<variation>S</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17857295." id="VAR_048610" evidence="16 17 19 20">
<original>Q</original>
<variation>E</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7262903." id="VAR_048611" evidence="17 18 21">
<original>Q</original>
<variation>K</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7269320." id="VAR_018448" evidence="17 18 21">
<original>S</original>
<variation>F</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs filament formation and abolishes antiviral signaling activity." evidence="48">
<original>E</original>
<variation>A</variation>
<variation>R</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs ability to induce IFN-beta. Loss of interaction with the ATG5-ATG12 conjugate." evidence="18 28">
<original>T</original>
<variation>A</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs filament formation and abolishes antiviral signaling activity." evidence="48">
<original>W</original>
<variation>A</variation>
<variation>E</variation>
<variation>R</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs ability to induce IFN-beta." evidence="18">
<original>GWV</original>
<variation>AAA</variation>
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="No interaction with TRAF2." evidence="20">
<original>Q</original>
<variation>N</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of cleavage by Seneca Valley virus protease 3C." evidence="57">
<original>Q</original>
<variation>A</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="mutagenesis site" description="No interaction with TRAF6; when associated with D-457." evidence="20">
<original>E</original>
<variation>D</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by Seneca Valley virus protease 3C." evidence="57">
<original>Q</original>
<variation>A</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by Seneca Valley virus protease 3C." evidence="57">
<original>Q</original>
<variation>A</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by Seneca Valley virus protease 3C." evidence="57">
<original>Q</original>
<variation>A</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by Seneca Valley virus protease 3C." evidence="57">
<original>Q</original>
<variation>A</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of cleavage by protease 2A of enterovirus 71." evidence="55">
<original>G</original>
<variation>A</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of cleavage by protease 2A of enterovirus 71." evidence="55">
<original>G</original>
<variation>A</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of cleavage by enterovirus 71." evidence="55">
<original>G</original>
<variation>A</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="No cleavage by HHAV 3ABC." evidence="25">
<original>Q</original>
<variation>A</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by NS3/4A protease complex." evidence="22">
<original>C</original>
<variation>R</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished ability to bind and activate IRF3." evidence="51 52">
<original>S</original>
<variation>A</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by NS3/4A protease complex." evidence="22">
<original>C</original>
<variation>R</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="mutagenesis site" description="No interaction with TRAF6; when associated with D-155." evidence="20">
<original>E</original>
<variation>D</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by HHAV 3ABC." evidence="25">
<original>E</original>
<variation>A</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="mutagenesis site" description="No cleavage by HCV and hepatitis GB virus B NS3/4A protease complex." evidence="21 22 24">
<original>C</original>
<variation>A</variation>
<variation>R</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; BAC77356." ref="8" evidence="61">
<original>L</original>
<variation>P</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; BAF84474." ref="9" evidence="61">
<original>T</original>
<variation>N</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; BAC77356." ref="8" evidence="61">
<original>A</original>
<variation>V</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; BAC77356." ref="8" evidence="61">
<original>S</original>
<variation>P</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="3"/>
<end position="14"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="16"/>
<end position="19"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="24"/>
<end position="27"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="28"/>
<end position="30"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="36"/>
<end position="49"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="51"/>
<end position="62"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="68"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="82"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="456"/>
<end position="459"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="504"/>
<end position="507"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MS8"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2VGQ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3RC5"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Z8M"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEK"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8VCF0"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255"/>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11780052"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16125763"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16127453"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16153868"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16177806"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16301520"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17020950"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17093192"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17438296"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17460044"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17600090"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17709747"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18200010"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18636086"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19164550"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19416887"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19419966"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19631370"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19734229"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19881509"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20127681"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20451243"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21170385"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21436888"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21813773"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22383950"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23087404"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23399697"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23545497"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23711367"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24390337"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24569476"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25018021"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25135833"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25636800"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27302953"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27980081"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28011935"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28253362"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28414768"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28566380"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31522117"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18207245"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000305"/>
<evidence key="62" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:29233"/>
</source>
</evidence>
<sequence length="540" mass="56528" checksum="0E23E3E115941EE8" modified="2004-05-10" version="2">MPFAEDKTYKYICRNFSNFCNVDVVEILPYLPCLTARDQDRLRATCTLSGNRDTLWHLFNTLQRRPGWVEYFIAALRGCELVDLADEVASVYQSYQPRTSDRPPDPLEPPSLPAERPGPPTPAAAHSIPYNSCREKEPSYPMPVQETQAPESPGENSEQALQTLSPRAIPRNPDGGPLESSSDLAALSPLTSSGHQEQDTELGSTHTAGATSSLTPSRGPVSPSVSFQPLARSTPRASRLPGPTGSVVSTGTSFSSSSPGLASAGAAEGKQGAESDQAEPIICSSGAEAPANSLPSKVPTTLMPVNTVALKVPANPASVSTVPSKLPTSSKPPGAVPSNALTNPAPSKLPINSTRAGMVPSKVPTSMVLTKVSASTVPTDGSSRNEETPAAPTPAGATGGSSAWLDSSSENRGLGSELSKPGVLASQVDSPFSGCFEDLAISASTSLGMGPCHGPEENEYKSEGTFGIHVAENPSIQLLEGNPGPPADPDGGPRPQADRKFQEREVPCHRPSPGALWLQVAVTGVLVVTLLVVLYRRRLH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

